T. Steininger

Long-term remission of a Her2/neu positive primary breast cancer under double monoclonal antibody therapy with trastuzumab and bevacizumab

C. Dittrich, R. Königsberg, J. Maierhofer, 2014, Radiology and oncology.

Validation of a simple assay for the quantification of the capecitabine metabolites 5'-DFCR and 5'-DFUR for drug monitoring in patients receiving outpatient chemotherapy.

C. Dittrich, M. Czejka, P. Buchner, 2013, Anticancer research.

Clinical and Economic Aspects of KRAS Mutational Status as Predictor for Epidermal Growth Factor Receptor Inhibitor Therapy in Metastatic Colorectal Cancer Patients

C. Dittrich, M. Klimpfinger, R. Königsberg, 2012, Oncology.

Disposition of Erlotinib and Its Metabolite OSI420 in a Patient with High Bilirubin Levels

C. Dittrich, M. Czejka, P. Buchner, 2013, Case Reports in Oncology.

Combined chemoradiotherapy with gemcitabine in patients with locally advanced inoperable transitional cell carcinoma of the urinary bladder and/or in patients ineligible for surgery: a phase I trial.

M. D. De Santis, F. Sedlmayer, C. Dittrich, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.